APA (7th ed.) Citation

Ucpinar, S., Kwan, J. K., Hoffman, J. D., Tilley, M. K., Douglas, J. A., Rubio, R. G., . . . Langrish, C. L. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral allosteric TYK2 inhibitor ESK‐001 using a randomized, double‐blind, placebo‐controlled study design. Wiley.

Chicago Style (17th ed.) Citation

Ucpinar, Sibel, Joyce K. Kwan, Joshua D. Hoffman, Mera K. Tilley, Jeffrey A. Douglas, Roman G. Rubio, Ruixiao Lu, Philip A. Nunn, and Claire L. Langrish. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral Allosteric TYK2 Inhibitor ESK‐001 Using a Randomized, Double‐blind, Placebo‐controlled Study Design. Wiley.

MLA (9th ed.) Citation

Ucpinar, Sibel, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral Allosteric TYK2 Inhibitor ESK‐001 Using a Randomized, Double‐blind, Placebo‐controlled Study Design. Wiley.